Liv 52 - Research Viral Hepatitis

Liv.52 tablets can bestow clinical and biochemical improvement by virtue of a direct, hepatocellular, regenerative and stimulating effect. About 60% cases of acute and chronic hepatitis of this nature benefited substantially with Liv.52 only. To read more about this study, visit A study of serum glycolytic enzymes and serum B hepatitis in relation to Liv52 therapy - Patney, N.L. and Sumanbala Pachori, The Medicine and Surgery (1986): (XXVI), 4, 9.

One hundred and thirty cases of viral hepatitis in children admitted to Medical College Hospital, Aurangabad were studied. The ages of these children ranged from 5 months to 12 years the highest incidence was in the age group 4-7 years the majority of them (65%) belonged to the poor socio-economic group. Jaundice had lasted for less than 10 days prior to admission in 50% of cases. Mortality rate was 3.8%. Complete biochemical recovery took 8-10 weeks in the majority of the cases. To read more about this study, visit Viral hepatitis in children - Chawhan, R.N., Talib, S.H., Talib, V.H., Sengupta, S.R. and Patil, S.D., The Medicine and Surgery (1976): 3, 9.

All research studies and clinical trials on efficacy of Liv-52 in Hepatitis

  1. Evaluation of efficacy and safety of Liv.52 DS tablets in acute viral hepatitis: A prospective, double-blind, randomized, placebo-controlled, phase III clinical trial (pdf)
    Dr. Rajiv Baijal, M.D., D.N.B.1, Dr. Nikhil Patel, M.D.,2 and Dr. S. A. Kolhapure, M.D.3* 1Gastroenterologist, 2Research Associates, Department of Gastroenterology, Jagjivanram Western Railway Hospital, Mumbai Central, Mumbai, India, 3Senior Medical Advisor, R&D Center, The Himalaya Drug Company, Bangalore, India, Medicine Update 2004; 12(5), 41-53.


  2. Meta-analysis of 50 Phase III clinical trials in evaluation of efficacy and safety of Liv.52 in infective hepatitis (pdf)
    Kolhapure, S.A., M.D., Senior Medical Advisor, and Mitra, S.K., M.D., Executive Director,Research and Technical Service, R&D Center, The Himalaya Drug Company, Bangalore, India, Medicine Update (2004): 12(2), 51-61.


  3. Comparative efficacy of five indigenous compound formulations in patients of acute viral hepatitis (pdf)
    Dange, S.V., Lecturer, Patki, P.S., Reader, Pawar, S.S., Laboratory Technician, Phadke, S.A., Associate Professor and Shrotri, D.S., Professor and Head, Departments of Pharmacology and Microbiology, B.J. Medical College, Pune, India, Maharashtra Medical Journal (1989): (XXXVI), 5, 75.


  4. A trial with Liv.52 in infective hepatitis (pdf)
    Vijaykumar, S. Karchi, X-ray Unit, Talkoti, Karnataka, Capsule (1988): Feb./Mar.,126.


  5. A study of serum glycolytic enzymes and serum B hepatitis in relation to Liv.52 therapy (pdf)
    Patney, N.L. and Sumanbala Pachori, Postgraduate Department of Medicine, S.N. Medical College, Agra, Uttar Pradesh, The Medicine and Surgery (1986): (XXVI), 4, 9.


  6. Liv.52 in infective hepatitis including precoma and coma (pdf)
    Phadke, M.A. (Mrs.), Alka Datar and Nainesh M. Vora, B.J. Medical College and Sassoon General Hospitals, Pune, Maharashtra, Capsule (1984): (22), 8, 170.


  7. Studies with Liv.52 in the treatment of infective hepatitis, chronic active hepatitis and cirrhosis of the liver (pdf)
    Mandal, J.N. and Roy, B.K., Department of Medicine, Medical College and Hospital, Calcutta, West Bengal, Probe (1983): (XXII), 4, 217.


  8. Antiviral activity of plant extract Liv.52 in mice experimentally infected with Semliki forest encephalitis virus (pdf)
    Singh, V.K., George, C.X., Gupta, K.P. and Gupta, B.M., Central Drug Research Institute, Lucknow, Uttar Pradesh, Science and Culture (1983): 49, 354.


  9. Management of infective hepatitis (pdf)
    Sreenivasa Rao, Y., I.S.&W.P. Hospital, Jamshedpur, Bihar, Probe (1983): (XXII), 2, 107.


  10. Role of Liv.52 in the treatment of infective hepatitis (pdf)
    Chowdhury, A.B., Government Subdivisional Hospital, Karimganj, Cachar District, Assam, Capsule (1981): 3, 50.


  11. Infective hepatitis and Liv.52 drops (pdf)
    Dinesh Chandra Misra, Primary Health Centre, Marteengaj, Azamgarh, Uttar Pradesh, Capsule (1981): 6, 122.


  12. Liv.52 therapy in acute infective hepatitis (pdf)
    Kesarkar, A.S., S.V. Road, Goregaon West, Bombay, Maharashtra, Capsule (1981): 4, 74.


  13. Role of Liv.52 in the treatment of infective hepatitis (pdf)
    Paritosh Biswas, Ashoke Nagar, (24 Parganas), Alipur, West Bengal, Capsule (1980): 4, 74.


  14. Study of Liv.52 therapy in infective hepatitis in children (pdf)
    Shakuntala Saxena, (Mrs.), Ashok Kumar Garg and Ashok Jain, Department of Paediatrics, S.M.S. Medical College and Hospital, Jaipur, Rajasthan, Current Medical Practice (1980): (24), 5, 194.


  15. Viral hepatitis and Liv.52 (pdf)
    Uday Shankar Mandal, Giridih Block, Sirsia, Giridih, Bihar, Capsule (1980): 3, 50.


  16. Liv.52 in acute viral hepatitis – Results of a double-blind study (pdf)
    Habibullah, C.M., Vinod Chandra, Padmanaban, C.G. and Ramakrishna, R., Department of Gastroenterology, Osmania General Hospital, Hyderabad, Andhra Pradesh, The Antiseptic (1978): (75), 8, 491.


  17. Effect of an indigenous preparation Liv.52 on hepatitis B antigen-carriage (pdf)
    Kelkar, S.S., Grant Medical College, Bombay, Maharashtra, and Mahajan, R.K., Medical College, Aurangabad, Maharashtra, Probe (1978): (XVII), 2, 150.


  18. A preliminary report on the role of Liv.52, an indigenous drug in serum B hepatitis (Australia antigen positive) cases (pdf)
    Patney, N.L. and Ashok Kumar, Postgraduate Department of Medicine, S.N. Medical College, Agra, Uttar Pradesh, Probe (1978): (XVII), 2, 132.


  19. Clinical management of severe acute hepatic failure with special reference to Liv.52 therapy (pdf)
    Sethi, J.P. and Madhulika Sharma, Department of Medicine, S.M.S. Medical College and Hospital, Jaipur, Rajasthan, Probe (1978): (XVII), 2, 155.


  20. Liv.52 therapy in viral hepatitis (A clinico-biochemical study) (pdf)
    Banerjee, L.K., Sahu, N.N., Ray, S.S. and Daljit Singh, BSF Base Hospital, Kadamtala, Siliguri, Darjeeling, West Bengal, Capsule (1977): 8, 170.


  21. A clinical study of infective hepatitis treated with Liv.52 (pdf)
    Ila V. Desai, Dudhia, M.V. and Gandhi, V.K., Sheth K.M. School of Postgraduate Medicine and Research, and Sheth V.S. General Hospital and Smt. N.H.L. Municipal Medical College, Ahmedabad, Gujarat, Indian Paediatrics (1977): 3, 197.


  22. Observations on the treatment of infective hepatitis with an indigenous drug Liv.52 (pdf)
    Singh, K.K., Department of Medicine, Singh, Y.K., Sinha, S.K., Department of Paediatrics, Sharma, V., Department of Medicine and Mishra, B.N., Department of Medicine, Darbhanga Medical College, Laheriasarai, Bihar, Indian Medical Journal (1977): 5, 69.


  23. Clinical trial of Liv.52 drops in infective hepatitis – A comparative study with broad spectrum antibiotics and corticosteroids (pdf)
    Agrawal, V.K. and Meena Sareen, M.L.N. Medical College, Allahabad, Uttar Pradesh, Probe (1976): (XV), 2, 112.


  24. Viral hepatitis in children (pdf)
    Chawhan, R.N., Talib, S.H., Talib, V.H., Sengupta, S.R. and Patil, S.D., Medical College, Aurangabad, Uttar Pradesh, The Medicine and Surgery (1976): 3, 9.


  25. Efficacy of an indigenous compound preparation Liv.52 in acute viral hepatitis – A double-blind study (pdf)
    Sama, S.K., Krishnamurthy, L., Ramachandran, K. and Krishnan Lal, All India Institute of Medical Sciences, Ansari Nagar, New Delhi, Indian Journal of Medical Research (1976): 5, 738.


  26. A study of chronic hepatitis in northern India (pdf)
    Singh, D.S., Jawaharlal Institute of Postgraduate Medical Education and Research, Pondicherry, Sama, S.K., Sir Ganga Ram Hospital, New Delhi and Singh, G., Department of Gastroenterology, All India Institute of Medical Sciences, New Delhi, Indian Journal of Medical Research (1976): (64), 12,1728.


  27. Viral hepatitis in children (pdf)
    Reddi, Y.R., Sudhakar Rao, V., Rohini, K. and Kusuma, G., Institute of Child Health, Niloufer Hospital, Hyderabad, Andhra Pradesh, Indian Paediatrics (1975): (XII), 8, 659.


  28. Studies on Liv.52 in hepatic disorders – Part II (pdf)
    Sharma, N.L., Lahori, U.C. and Mehta, S.K., King George Medical College, Lucknow, Uttar Pradesh, Probe (1975): (XIV), 2, 126.


  29. Liv.52 in infective hepatitis (pdf)
    Bhandari, N.R. and Shashi Gupta (Miss.), Department of Paediatrics, Gandhi Medical College, Bhopal, Madhya Pradesh, Probe (1974): (XIV), 1, 68.


  30. Acute infectious hepatitis with fulminant hepatic failure – A study of 289 cases (pdf)
    Deshpande, R.S., Kasturba Hospital for Infectious Diseases, Sane Guruji Marg, Bombay, Maharashtra, Probe (1974): (XIV), 1, 1.


  31. Trial of Liv.52 in infectious hepatitis in children in Goa (pdf)
    Harish Mazumdar and Mira Mazumdar, Department of Paediatrics, Goa Medical College, Panaji, Goa, Probe (1974): (XIV), 1, 28.


  32. Studies with Liv.52 in infective hepatitis (pdf)
    Jain, K.C., Khanijo, S.K. and Bisarya, B.N., Department of Medicine, S.S. Medical College, Rewa, Madhya Pradesh, Probe (1974): (XIV), 1, 64.


  33. Liv.52 therapy in infective hepatitis (pdf)
    Khetarpal, S.K. and Veera Kumar, E., Department of Paediatrics, Medical College, Amritsar, Punjab, Probe (1974): (XIV), 1, 59.


  34. Trial of Liv.52 in infectious hepatitis in children in Goa (pdf)
    Mazumdar, H. and Mazumdar, M., Department of Paediatrics, Goa Medical College, Panaji, Goa, Probe (1974): (XIV), 1, 82.


  35. Liv.52 in viral hepatitis with special reference to its use in precoma and coma (pdf)
    Mitra, D.K., Ashrafuddin, S. and Talib, S.H., Department of Medicine, Medical College, Aurangabad, Maharashtra, Probe (1974): (XIV), 1, 14.


  36. Role of Liv.52 and steroids in the management of viral hepatitis in children (pdf)
    Reddi, Y.R., Rohini, K., Kusuma, G. and Sudhakar Rao, V., Osmania Medical College, Institute of Child Health and Niloufer Hospital, Hyderabad, Andhra Pradesh, Probe (1974): (XIV), 1, 35.


  37. Studies on Liv.52 in hepatic disorders – Part I (pdf)
    Sharma, N.L., Lahori, U.C. and Mehta, S.K., King George Medical College, Lucknow, Uttar Pradesh, Probe (1974): (XIV), 1, 54.


  38. Observations on the therapy of acute infectious hepatitis with Liv.52 (pdf)
    Shishupal Ram and Kumar, P., Liver Research Unit, Hospital for Children, Patna Medical College Hospital, Patna, Bihar, Probe (1974): (XIV), 1, 66.


  39. Studies on 222 cases of acute infective hepatitis during an epidemic (pdf)
    Sinha, B.B., Kurzi Holy Family Hospital, Patna, Bihar, Probe (1974): (XIII), 3, 130.


  40. Liv.52 trial in infective hepatitis (pdf)
    Mehrotra, M.P.,and Dineshchandra Mathur, Research Fellow, S.N. Medical College, Agra, Uttar Pradesh, The Antiseptic (1973): (70), 2, 114.


  41. Liv.52 in the treatment of acute infective hepatitis (pdf)
    Sarkar, M.K., Burn and Co., Durgapur, Burdwan, Rajasthan, The Indian Practitioner (1973): 8, 395.


  42. Clinico-biochemical study of infective hepatitis with special reference to Liv.52 therapy (pdf)
    Dave, D.S., Rajput, V.J. and Gupta, M.R., Department of Paediatrics, G.R. Medical College, Gwalior, Madhya Pradesh, Probe (1972): (XI), 4, 214.


  43. Therapeutic effects of Liv.52 in post-necrotic hepatitis (pdf)
    Gupta, S., Khatri, R.L. and Srivastava, G., Maulana Azad Medical College, New Delhi, Probe (1972): (XII), 1, 15.


  44. Therapy of infectious hepatitis and other liver disorders (pdf)
    Gupta, S., Khatri, R.L. and Srivastava, G., Maulana Azad Medical College, New Delhi, Probe (1972): (XI), 2, 93.


  45. Liv.52 therapy in viral hepatitis (pdf)
    Patel, G.T., Mruthyunjayanna, B.P., Seetharam, T.D. and Channe Gowda, A.C., Medicine Unit, Victoria Hospital and Bangalore Medical College, Bangalore, Karnataka, Probe (1972): (XI), 2, 112.


  46. Chronic active hepatitis (A preliminary observation of 10 cases) (pdf)
    Dasgupta, M. and Mukerjee, A.B., Department of Medicine, R.K. Mission Seva Pratisthan, Calcutta, West Bengal, Journal of Indian Medical Profession (1971): 18, 8097.


  47. Infectious hepatitis – Study of 100 cases (pdf)
    Deshpande, R.S., Kasturba City Fever Hospital, Bombay, Maharashtra, Shantilal C. Sheth, Kasturba City Fever Hospital and Emeritus Director Professor of Paediatrics, Topiwala National Medical College and Nair Hospital, Bombay, Maharashtra, and Joy Kutty, M.D., Research Scholar, Bombay, Maharashtra, Current Medical Practice (1971): 6, 810.


  48. Some observations on Liv.52 in the treatment of infective hepatitis and cirrhosis of liver (pdf)
    Lala Surajnandan Prasad, Department of Paediatrics, Patna University, and Kaleshwer Prasad, Department of Paediatrics, Children’s Hospital, Patna Medical College and Hospital, Patna, Bihar, Probe (1971): (X), 3, 114.


  49. Liv.52 studies in acute hepatitis (pdf)
    Ramalingam, V., Sundarvalli, N. and Balagopal Raju, V., Institute of Child Health and Hospital for Children, Egmore, Madras, Tamil Nadu, Indian Paediatrics (1971): 12, 839.


  50. Infective hepatitis – Survey and study of 110 cases (pdf)
    Doddagoudar, M.B., Karnatak Medical College, Hubli, Karnataka, Probe (1970): (IX), 3, 122.


  51. Treatment of viral hepatitis by an indigenous drug – Liv.52 (pdf)
    Mukerjee, A.B., Calcutta National Medical College and Hospitals, and Department of Medicine,Dasgupta, M., Ramakrishna Mission Seva Pratishthan, Calcutta, West Bengal, The Indian Practitioner (1970): June, 357.


  52. Liv.52 in infective hepatitis (pdf)
    Jaffari, S.M.H. and Shyam Raj, Fever Hospital, Hyderabad, Andhra Pradesh, The Antiseptic (1969): 5, 353.


  53. Role of various types of treatment in infectious hepatitis (pdf)
    Major Arora, J.K., MH Lebong, Darjeeling, West Bengal, Armed Forces Medical Journal (1969): (XXV), 3, 362.


  54. Studies with Liv.52 therapy in infective hepatitis (pdf)
    Sule, C.R., Pai, V.R., Damania, R.F. and Joshi, V.S. (Miss.), Medicine Unit, Sasoon General Hospitals and B.J. Medical College, Poona, Maharashtra, Journal of Indian Medical Profession (1968): 14, 6391.


  55. Preliminary observations on the role of Liv.52 in infective-hepatitis with persistent jaundice (pdf)
    Rath, B.B., Department of Medicine, Sengupta, S.N., Department of Medicine, and Bose, S.N., Department of Biochemistry, Bankura Sammilani Medical College and Hospital, Bankura, West Bengal, Capsule (Undated): (XV), 8, 170.

























Home

The Products
Liv 52 Range
Liv 52 Regular Strength
Liv 52 Double Strength
Liv 52 Drops
Liv 52 HB


Deals
Combination Deals
Bodybuilder Deals
Wholesale

Product Information
Liv 52 FAQ
Liv 52 How It works
Liv 52 Ingredients
Liv 52 Dosage
Liv 52 Vs Milk Thistle
Liv 52 Research Papers

Shipping & Returns
Terms & Conditions
Privacy Policy

About Us
Contact Us
Disclaimer











© 2012 Liv-52.co.uk